Clinical Trial Update: A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of Daprodustat (QLG1218) in Chinese hemodialysis-dependent patients with anemia due to chronic kidney disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Daprodustat (daprodustat)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Anaemia | Phase 3 | Status: NOT_YET_RECRUITING